Identification and functional characterization of the natural variant MRP3-Arg1297 His of human multidrug resistance protein 3 (MRP3/ABCC3)

被引:63
作者
Lee, YMA
Cui, YH
König, J
Risch, A
Jäger, B
Drings, P
Bartsch, H
Keppler, D
Nies, AT [1 ]
机构
[1] Deutsch Krebsforschungszentrum, Div Tumour Biochem, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Div Toxicol & Canc Risk Factors, D-69120 Heidelberg, Germany
[3] Thoraxklin Heidelberg Rohrbach, Heidelberg, Germany
来源
PHARMACOGENETICS | 2004年 / 14卷 / 04期
关键词
basolateral membrane; cholestasis; hepatocellular transporters; MRP3; polymorphism; SNP;
D O I
10.1097/00008571-200404000-00001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The human multidrug resistance protein 3 (MRP3, symbol ABCC3) is an ATP-binding cassette transporter that mediates the efflux of organic anions, including lipophilic substances conjugated with glucuronate, sulphate or glutathione, across the basolateral membrane of polarized cells (e.g. hepatocytes) into blood. Genetic variants of MRP3 may affect the transport of these substances out of cells. The aims of this study were: (i) to identify MRP3 polymorphisms; (ii) to functionally characterize one relatively frequent MRP3 polymorphism; and (iii) to establish whether MRP3 transports bilirubin glucuronosides. Exonic nucleotide variants in the ABCC3 gene were identified by single-strand conformation polymorphism analysis. The 3890G>A mutation, resulting in MRP3-Arg(1297) His, was introduced into the ABCC3 cDNA which was stably transfected into MDCKII cells. For the functional characterization of MRP3-Arg(1297) His in comparison with MRP3, ATP-dependent transport was analysed in isolated membrane vesicles. Two non- synonymous MRP3 variants were identified with an allele frequency of 0.003 for 1643T>A (MRP3-Leu(148)Gln) and 0.08 for 3890G>A (MRP3-Arg(1297) His). Because of the high, frequency of the 3890G>A mutation, and because of the close proximity of Arg(1297) to the second nucleotide-binding domain, we pursued the functional characterization of the MRP3-Arg(1297)His polymorphic variant. MRP3-Arg(1297)His was correctly localized to the basolateral membrane of polarized MDCKII cells. We identified monoglucuronosyl bilirubin, bisgiucuronosyl bilirubin and leukotriene C-4 as substrates for both MRP3 and MRP3-Arg(1297)His. Dehydroepiandrosterone-3-sulphate and 17beta-glucuronosyl oestradiol were transported with similar kinetics by MRP3 and MRP3-Arg(1297) His. This experimental setup provides a useful tool to analyse the functional consequences of polymorphic variants of MRP3. Pharmacogenetics 14: 213-223 (C) 2004 Lippincott Williams Wilkins
引用
收藏
页码:213 / 223
页数:11
相关论文
共 51 条
  • [1] Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3
    Akita, H
    Suzuki, H
    Hirohashi, T
    Takikawa, H
    Sugiyama, Y
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (01) : 34 - 41
  • [2] Buchler M, 1996, J BIOL CHEM, V271, P15091
  • [3] Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) rnRNA and hepatic induction of mrp3 by constitutive androstane receptor activators in rats
    Cherrington, NJ
    Hartley, DP
    Li, N
    Johnson, DR
    Klaassen, CD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (01) : 97 - 104
  • [4] CHOWDHURY NR, 2001, LIVER BIOL PATHOBIOL, P291
  • [5] A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance
    Conrad, S
    Kauffmann, HM
    Ito, K
    Leslie, EM
    Deeley, RG
    Schrenk, D
    Cole, SPC
    [J]. PHARMACOGENETICS, 2002, 12 (04): : 321 - 330
  • [6] Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution
    Conrad, S
    Kauffmann, HM
    Ito, K
    Deeley, RG
    Cole, SPC
    Schrenk, D
    [J]. JOURNAL OF HUMAN GENETICS, 2001, 46 (11) : 656 - 663
  • [7] Cui YH, 1999, MOL PHARMACOL, V55, P929
  • [8] Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats
    Dietrich, CG
    De Waart, DR
    Ottenhoff, R
    Schoots, IG
    Elferink, RPJO
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (05) : 974 - 980
  • [9] Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver
    Donner, MG
    Keppler, D
    [J]. HEPATOLOGY, 2001, 34 (02) : 351 - 359
  • [10] Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome
    Hashimoto, K
    Uchiumi, T
    Konno, T
    Ebihara, T
    Nakamura, T
    Wada, M
    Sakisaka, S
    Maniwa, F
    Amachi, T
    Ueda, K
    Kuwano, M
    [J]. HEPATOLOGY, 2002, 36 (05) : 1236 - 1245